Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Kymera Therapeutics Inc (NASDAQ: KYMR) closed at $44.26 in the last session, up 1.56% from day before closing price of $43.58. In other words, the price has increased by $1.56 from its previous closing price. On the day, 1.14 million shares were traded.
Ratios:
We take a closer look at KYMR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.49 and its Current Ratio is at 8.49. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
On June 03, 2025, B. Riley Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $60.
BofA Securities Upgraded its Neutral to Buy on June 02, 2025, while the target price for the stock was maintained at $51.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 03 ’25 when Esposito Pamela sold 5,000 shares for $49.04 per share. The transaction valued at 245,186 led to the insider holds 0 shares of the business.
Ridloff Elena sold 12,000 shares of KYMR for $553,200 on Jun 03 ’25. The Director now owns 0 shares after completing the transaction at $46.10 per share. On Jun 03 ’25, another insider, Mainolfi Nello, who serves as the Chief Executive Officer of the company, sold 30,000 shares for $49.00 each. As a result, the insider received 1,470,000 and left with 660,482 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 48.95 while its Price-to-Book (P/B) ratio in mrq is 3.67.
Stock Price History:
Over the past 52 weeks, KYMR has reached a high of $53.27, while it has fallen to a 52-week low of $19.44. The 50-Day Moving Average of the stock is 48.35%, while the 200-Day Moving Average is calculated to be 12.12%.
Shares Statistics:
A total of 65.11M shares are outstanding, with a floating share count of 53.22M. Insiders hold about 18.27% of the company’s shares, while institutions hold 95.94% stake in the company.
Earnings Estimates
Its stock is currently analyzed by 15.0 different market analysts. The consensus estimate for the next quarter is -$0.93, with high estimates of -$0.59 and low estimates of -$1.12.
Analysts are recommending an EPS of between -$2.61 and -$4.25 for the fiscal current year, implying an average EPS of -$3.6. EPS for the following year is -$4.0, with 17.0 analysts recommending between -$1.91 and -$5.4.
Revenue Estimates
A total of 20 analysts have provided revenue estimates for KYMR’s current fiscal year. The highest revenue estimate was $225M, while the lowest revenue estimate was $22.1M, resulting in an average revenue estimate of $75.3M. In the same quarter a year ago, actual revenue was $47.07M
